Primary Cilia in Hepatic Biliary Hyperplasia: Implications for Liver Diseases
Seminars in Liver Disease · 01.09.2025 · 45 (03) · 348-361
DOI: 10.1055/a-2563-9791 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Liver Disease, erschienen am 01.09.2025. Verfasst von Kishor Pant und 2 weiteren Autor:innen. Beteiligte Einrichtung: The Hormel Institute, University of Minnesota, Austin, Minnesota. Hauptthemen laut MEDLINE: Cilia, Liver Diseases, Ciliopathies. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, National Institutes of Health Grant, Cholangiocarcinoma Foundation.
Abstract (Originalsprache)
Primary cilia, hair-like projections on the surface of various cell types, play crucial roles in sensing and regulating environmental cues within the liver, particularly among cholangiocytes. These structures detect changes in bile composition, flow, and other biochemical signals, integrating this information to modulate cellular processes. Dysfunction in cholangiocyte cilia—whether due to structural abnormalities or genetic mutations—has been linked to an array of cholangiopathies and ciliopathies. These include conditions such as biliary atresia, cholangiocarcinoma, primary sclerosing cholangitis, and polycystic liver diseases, each with distinct clinical phenotypes influenced by impaired ciliary function. Given the complexity of the ciliary proteome and its role in cellular signaling, including the Hedgehog, Wnt, and TGR5 pathways, ciliary dysfunction disrupts essential signaling cascades, thus driving disease progression. While over 40 gene mutations are associated with ciliopathic features, there may be additional contributors within the expansive ciliary proteome. This study synthesizes current knowledge on cholangiocyte cilia, emphasizing their mechanistic role in liver disease, and highlights emerging therapeutic strategies aimed at restoring ciliary function. In conclusion, ciliotherapies are proposed as a promising approach for addressing cholangiopathies, with the potential to shift the current therapeutic landscape.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- The Hormel Institute, University of Minnesota, Austin, Minnesota.
- Masonic Cancer Centre, University of Minnesota, Minneapolis, Minnesota.
Förderung
- NIDDK NIH HHS
- National Institutes of Health Grant
- Cholangiocarcinoma Foundation
- The Hormel Foundation
Zitieren
APA
Pant, K., Peixoto, E., & Gradilone, S. A. (2025). Primary Cilia in Hepatic Biliary Hyperplasia: Implications for Liver Diseases. Seminars in Liver Disease, 45(03), 348-361. https://doi.org/10.1055/a-2563-9791
Vancouver
Pant K, Peixoto E, Gradilone SA. Primary Cilia in Hepatic Biliary Hyperplasia: Implications for Liver Diseases. Seminars in Liver Disease. 2025;45(03):348-361. doi:10.1055/a-2563-9791
BibTeX
@article{Pant2025,
author = {Pant, Kishor and Peixoto, Estanislao and Gradilone, Sergio A},
title = {Primary Cilia in Hepatic Biliary Hyperplasia: Implications for Liver Diseases},
journal = {Seminars in Liver Disease},
year = {2025},
volume = {45},
number = {03},
pages = {348--361},
doi = {10.1055/a-2563-9791}
}
EUVIMED